Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 1356293)

Published in Ann Surg on June 01, 2004

Authors

Kevin M Reavis1, Cynthia D Morris, Deepak V Gopal, John G Hunter, Blair A Jobe

Author Affiliations

1: Department of Surgery, Oregon Health and Science University and Portland VA Medical Center, Portland, OR, USA.

Articles citing this

Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol (2007) 1.96

A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol (2013) 1.40

Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus. Am J Gastroenterol (2010) 1.10

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? Br J Cancer (2009) 0.97

Risk factors for laryngopharyngeal reflux. Eur Arch Otorhinolaryngol (2011) 0.85

The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study. Oncotarget (2016) 0.84

Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder. Surg Endosc (2006) 0.84

Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) (2013) 0.83

Aurora kinase A (AURKA) and never in mitosis gene A-related kinase 6 (NEK6) genes are upregulated in erosive esophagitis and esophageal adenocarcinoma. Exp Ther Med (2012) 0.80

Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma. Cancer (2014) 0.80

Screening for Barrett's Esophagus. Tech Gastrointest Endosc (2010) 0.78

Diabetes and risk of esophageal and gastric adenocarcinomas. Int J Cancer (2012) 0.77

Laryngopharyngeal reflux disease in the Greek general population, prevalence and risk factors. BMC Ear Nose Throat Disord (2015) 0.77

Endoscopic management of Barrett esophagus. Nat Rev Gastroenterol Hepatol (2011) 0.75

Articles cited by this

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1998) 4.68

Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ (2000) 4.21

Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology (2002) 3.26

The changing epidemiology of esophageal cancer. Semin Oncol (1999) 2.65

Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology (2002) 2.38

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38

A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27

The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol (1999) 2.26

Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25

Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg (1993) 2.00

Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol (1997) 1.79

Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology (1997) 1.66

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol (2002) 1.49

Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control (1996) 1.35

Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology (1995) 1.28

Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci (2002) 1.19

Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol (1987) 1.17

Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci (2003) 1.05

The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res (2002) 1.00

Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux. J Gastrointest Surg (2001) 0.92

Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope (1998) 0.90

Pharyngeal pH monitoring in patients with posterior laryngitis. Otolaryngol Head Neck Surg (1999) 0.89

Pharyngo-UES contractile reflex in patients with posterior laryngitis. Laryngoscope (1998) 0.89

Outcomes of acid suppressive therapy in patients with posterior laryngitis. Otolaryngol Head Neck Surg (2001) 0.87

Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol (1999) 0.86

Pharyngeal acid reflux in patients with single and multiple otolaryngologic disorders. Otolaryngol Head Neck Surg (1999) 0.86

Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma. Br J Cancer (2001) 0.85

Prevalence of upper respiratory symptoms in patients with symptomatic gastroesophageal reflux disease. Am J Respir Crit Care Med (2001) 0.84

[Diagnostic omeprazole test in suspected reflux-associated chronic cough]. Pneumologie (1999) 0.79

Young patients with Barrett's oesophagus experience less reflux complaints. Digestion (2001) 0.79

Evaluation of gastroesophageal reflux in patients with laryngotracheal stenosis. Ann Otol Rhinol Laryngol (1998) 0.78

Articles by these authors

Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91

CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med (2007) 7.63

Oesophageal carcinoma. Lancet (2013) 5.48

Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA (2008) 3.53

Causes and prevention of laparoscopic bile duct injuries: analysis of 252 cases from a human factors and cognitive psychology perspective. Ann Surg (2003) 3.44

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44

Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc (2005) 3.23

Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial. J Am Coll Surg (2011) 3.14

International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg (2015) 2.61

Mesh complications after prosthetic reinforcement of hiatal closure: a 28-case series. Surg Endosc (2008) 2.34

The durability of laparoscopic Nissen fundoplication: 11-year outcomes. J Gastrointest Surg (2007) 2.32

Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol (2006) 2.07

Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease. Ann Surg (2013) 2.06

Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg (2002) 1.94

Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol (2003) 1.91

Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology (2004) 1.88

Outcomes after a decade of laparoscopic giant paraesophageal hernia repair. J Thorac Cardiovasc Surg (2009) 1.75

Predictors of technical skill acquisition among resident trainees in a laparoscopic skills education program. World J Surg (2008) 1.62

Endoscopic measurement of cardia circumference as an indicator of GERD. Gastrointest Endosc (2006) 1.59

Stapled-wedge Collis gastroplasty for the shortened esophagus. Am J Surg (2004) 1.55

Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol (2005) 1.55

Surface visualization at 3D endoluminal CT colonography: degree of coverage and implications for polyp detection. Gastroenterology (2006) 1.53

Operative reports: form and function. Arch Surg (2010) 1.51

Decreased conduit perfusion measured by spectroscopy is associated with anastomotic complications. Ann Thorac Surg (2011) 1.49

Antireflux surgery in patients with chronic cough and abnormal proximal exposure as measured by hypopharyngeal multichannel intraluminal impedance. JAMA Surg (2013) 1.46

Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46

EUS characteristics of Nissen fundoplication: normal appearance and mechanisms of failure. Gastrointest Endosc (2006) 1.43

Early ERCP for gallstone pancreatitis: for whom and when? J Gastrointest Surg (2008) 1.42

Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet (2003) 1.42

A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol (2013) 1.40

Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus. J Gastrointest Surg (2002) 1.31

Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A (2011) 1.29

Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg (2005) 1.27

When fundoplication fails: redo? Ann Surg (2005) 1.25

Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg (2008) 1.20

Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc (2007) 1.18

Laparoscopic repair of giant paraesophageal hernia results in long-term patient satisfaction and a durable repair. J Gastrointest Surg (2008) 1.17

Revisional bariatric surgery for failed restrictive procedures. Surg Obes Relat Dis (2007) 1.16

Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005-2008. J Gastrointest Surg (2010) 1.15

The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc (2007) 1.15

Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses. Ann Surg (2005) 1.14

Evaluation of submucosal lesions of the large intestine: part 1. Neoplasms. Radiographics (2007) 1.14

Barrett's esophagus: a review of the literature. J Gastrointest Surg (2011) 1.10

Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg (2011) 1.08

Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease. J Gastrointest Surg (2010) 1.08

Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology (2006) 1.08

Clinical review: Healing in gastrointestinal anastomoses, part I. Microsurgery (2006) 1.08

Endoscopic appraisal of the gastroesophageal valve after antireflux surgery. Am J Gastroenterol (2004) 1.07

Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg (2007) 1.07

Comparison of perioperative outcomes after combined thoracoscopic-laparoscopic esophagectomy and open Ivor-Lewis esophagectomy. Am J Surg (2010) 1.06

Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg (2005) 1.04

The national mortality burden and significant factors associated with open and laparoscopic cholecystectomy: 1997-2006. J Gastrointest Surg (2009) 1.03

The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Ann Surg (2007) 1.00

Evaluation of submucosal lesions of the large intestine: part 2. Nonneoplastic causes. Radiographics (2007) 1.00

The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging. J Gastrointest Surg (2007) 0.99

Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol (2011) 0.98

Childhood gastroesophageal reflux symptoms in adult patients. J Pediatr Gastroenterol Nutr (2002) 0.97

Impact of a CT colonography screening program on endoscopic colonoscopy in clinical practice. Am J Gastroenterol (2007) 0.95

Detection of ureaplasma DNA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors. Pediatr Res (2007) 0.94

Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol (2002) 0.94

Laparoscopic approach reduces likelihood of perioperative complications in patients undergoing adrenalectomy. Am Surg (2004) 0.94

Prospective randomized clinical trial comparing nitrous oxide and carbon dioxide pneumoperitoneum for laparoscopic surgery. J Am Coll Surg (2002) 0.93

A train the trainer model for integrating evidence-based medicine into a complementary and alternative medicine training program. Explore (NY) (2011) 0.93

American surgery and the Affordable Care Act. JAMA Surg (2014) 0.92

Functional lumen imaging probe to assess geometric changes in the esophagogastric junction following endolumenal fundoplication. J Gastrointest Surg (2011) 0.92

Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer. Surg Endosc (2013) 0.92

Transoral endoscopic inner layer esophagectomy: management of high-grade dysplasia and superficial cancer with organ preservation. J Gastrointest Surg (2009) 0.92

Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma. Arch Surg (2011) 0.91

Esophageal carcinoma. N Engl J Med (2015) 0.91

Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage I esophageal adenocarcinoma. Arch Surg (2009) 0.91

Management of long-term failure after colon interposition for benign disease. Am J Surg (2002) 0.90

Impact of a transfer center on interhospital referrals and transfers to a tertiary care center. Acad Emerg Med (2005) 0.90

Minimally invasive esophagectomy: the evolution and technique of minimally invasive surgery for esophageal cancer. World J Surg (2011) 0.89

Review of case-control studies related to breastfeeding and reduced risk of childhood leukemia. Pediatrics (2005) 0.89

Increased risk of preeclampsia among nulliparous pregnant women with idiopathic hematuria. Am J Obstet Gynecol (2002) 0.89

The role of positron emission tomography in esophageal cancer. Gastrointest Cancer Res (2008) 0.89

A model for gastric banding in the treatment of morbid obesity: the effect of chronic partial gastric outlet obstruction on esophageal physiology. Ann Surg (2006) 0.89

The incidence of hiatal hernia after minimally invasive esophagectomy. J Gastrointest Surg (2014) 0.89

Ten-year follow-up of laparoscopic Heller myotomy for achalasia shows durability. Surg Endosc (2007) 0.89

Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg (2011) 0.88

Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis. Cancer (2013) 0.88

2014 SSAT State-of-the-Art Conference: advances in diagnosis and management of gastroesophageal reflux disease. J Gastrointest Surg (2014) 0.88